Search

Vaxcyte Inc

Cerrado

SectorSanidad

56.22 -1.02

Resumen

Variación precio

24h

Actual

Mínimo

55.77

Máximo

56.96

Métricas clave

By Trading Economics

Ingresos

-284M

-605M

BPA

-1.97

Empleados

507

EBITDA

22M

-292M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+83.83% upside

Dividendos

By Acuity

Próximas Ganancias

2 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

1B

8.8B

Apertura anterior

57.24

Cierre anterior

56.22

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

113 / 339 Clasificación en Healthcare

Vaxcyte Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 sept 2026, 19:46 UTC

Vaxcyte Inc is trading modestly higher, having fluctuated throughout the day but remains below its 20-day moving average and near the lower end of its one-month range.

23 sept 2026, 20:02 UTC

Correlated Moves

Vaxcyte Inc shares fell sharply, influenced by a significant drop in the Direxion Daily S&P Biotech Bull 3X ETF and earlier session highs.

18 sept 2026, 20:02 UTC

Vaxcyte Inc shares fell sharply, reaching their lowest cumulative return since Thursday and remaining well below the 20-day moving average.

17 sept 2026, 20:07 UTC

Correlated Moves

Vaxcyte Inc is gaining, likely influenced by the SPDR S&P Biotech ETF's rise following positive Phase 3 results from Moderna's cancer vaccine.

16 sept 2026, 19:16 UTC

Macro Event

Vaxcyte Inc shares fell amid broader market volatility following the Federal Reserve's 25 basis point interest rate hike, remaining near the lower end of their one-month range.

14 sept 2026, 20:08 UTC

Vaxcyte Inc shares are higher today, reflecting broader market trends. Earlier in the session, the stock pulled back but remains above Friday's close.

9 sept 2026, 19:46 UTC

Vaxcyte Inc shares are lower today, fluctuating from an early gain to a mid-afternoon decline. The stock is near its one-month trading range low.

8 sept 2026, 23:31 UTC

Vaxcyte Inc shares declined in after-hours trading, now below their 20-day moving average and near the lower end of their one-month trading range.

4 sept 2026, 20:08 UTC

News

Vaxcyte Inc. appointed new executives and accelerated its timeline for trial data, with shares trading lower during Friday's session.

3 sept 2026, 20:14 UTC

News

Vaxcyte shares are lower in after-market hours following leadership appointments and narrowed guidance for VAX-31 topline data, now expected by October 2026.

2 sept 2026, 20:08 UTC

Vaxcyte Inc is gaining today, driven by strong performance in the Biotechnology sub-sector, despite earlier pulling back from a session high.

1 sept 2026, 20:09 UTC

Vaxcyte Inc shares are lower today, influenced by a broad market decline amid rising oil prices and increasing Treasury yields. No specific company news was identified.

31 ago 2026, 19:16 UTC

Vaxcyte Inc is trading higher since Friday's close, reflecting a positive performance backdrop. Shares remain above their 20-day moving average.

28 ago 2026, 20:07 UTC

Vaxcyte Inc shares are lower amid a broader market downturn. Rising U.S. Treasury yields and inflation concerns contribute to the decline in equity prices.

25 ago 2026, 20:07 UTC

Vaxcyte Inc. shares are lower today, having peaked earlier before drifting downwards. The broader market sees a drop in oil prices and Treasury yields.

24 ago 2026, 19:46 UTC

Vaxcyte Inc's shares are lower amid rising oil prices and geopolitical tensions. No specific company news was identified to explain the decline.

21 ago 2026, 21:01 UTC

Vaxcyte Inc is trading higher in after-market hours, maintaining a notable increase since Friday's close, amid positive market sentiment.

20 ago 2026, 23:46 UTC

Vaxcyte Inc shares are lower in after-market hours, with no specific news identified. Broader market declines may be affecting investor sentiment in biotechnology.

19 ago 2026, 20:02 UTC

Correlated Moves

Vaxcyte Inc. shares are higher during Wednesday's session, continuing a positive trend with strong investor interest. The stock aligns with gains in the biotechnology sector.

14 ago 2026, 20:06 UTC

Vaxcyte Inc's shares are lower today, breaking a trend of higher closes. This decline aligns with weaker-than-expected U.S. retail sales data for July.

12 ago 2026, 19:46 UTC

Vaxcyte Inc shares are higher today, supported by broader market gains following positive sentiment from the recent inflation report. The stock remains above its 20-day moving average.

11 ago 2026, 23:11 UTC

Vaxcyte Inc shares are higher in after-market trading, reflecting positive momentum despite no specific news driving the price action.

10 ago 2026, 19:56 UTC

Vaxcyte Inc shares are higher, continuing gains since Friday's close, reaching a peak earlier in the session. No specific news was identified for the move.

7 ago 2026, 21:01 UTC

Vaxcyte Inc shares are lower in after-market hours, continuing a weak trading session without any specific news to explain the decline.

6 ago 2026, 20:03 UTC

News

Vaxcyte reports a net loss of $284.3 million for Q2. Shares are trading higher as the company anticipates key Phase 3 trial data in 2027.

5 ago 2026, 19:16 UTC

Vaxcyte Inc. shares are higher today, aligning with broader market trends, despite no specific news identified. The stock remains near its one-month range low.

4 ago 2026, 20:21 UTC

Vaxcyte Inc. shares are lower in after-market trading, remaining flat since Tuesday's close and positioned below its 20-day moving average.

3 ago 2026, 19:46 UTC

Vaxcyte Inc's shares are lower today, continuing a decline since Friday. The stock is trading near the lower end of its one-month range.

31 jul 2026, 19:56 UTC

Correlated Moves

Shares lower amid broader sector sentiment; SPDR S&P Biotech ETF declines.

30 jul 2026, 18:52 UTC

Vaxcyte Inc's shares are higher today amid strong buying activity, reaching an intraday high but remain below the 20-day moving average.

Comparación entre iguales

Cambio de precio

Vaxcyte Inc previsión

Precio Objetivo

By TipRanks

83.83% repunte

Estimación a 12 Meses

Media 104.6 USD  83.83%

Máximo 133 USD

Mínimo 75 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Vaxcyte Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

5

Comprar

0

Mantener

0

Vender

Sentimiento

By Acuity

113 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.